Imunon, Inc. — Director's Dealing 2016

Feb 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-02-17

Reporting Person: Tardugno Michael H (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-17	Celsion Corporation Common Stock	P	2000	$1.268	Acquired	117521	Direct

Footnotes

F1: The Officer purchased the shares on the open market